T1	Pharmacological_substance 0 9	Methadone
N1000 	Reference T1 MeSH:D008691	Methadone
T2	Pharmacological_substance 38 52	antiretroviral
T3	Pharmacological_substance 71 81	nevirapine
N1001 	Reference T3 MeSH:D019829	nevirapine
T4	Pharmacological_substance 83 98	Antiretrovirals
T5	Pharmacological_substance 171 190	protease inhibitors
N1002 	Reference T5 MeSH:D011480	protease inhibitors
T6	Pharmacological_substance 263 273	nevirapine
N1003 	Reference T6 MeSH:D019829	nevirapine
T8	Pharmacological_substance 354 373	protease inhibitors
N1004 	Reference T8 MeSH:D011480	protease inhibitors
T9	Pharmacological_substance 383 397	contraceptives
N1005 	Reference T9 MeSH:D003270	contraceptives
T10	Pharmacological_substance 399 408	Methadone
N1006 	Reference T10 MeSH:D008691	Methadone
T11	Disorder 426 464	human immunodeficiency viral infection
N1 	Reference T11 UMLS:C0019693	human immunodeficiency viral infection
T12	Disorder 466 470	pain
N2 	Reference T12 UMLS:C0030193	pain
T13	Disorder 499 511	opioid abuse
N3 	Reference T13 UMLS:C0029095	opioid abuse
T14	Pharmacological_substance 561 570	methadone
N1007 	Reference T14 MeSH:D008691	methadone
T15	Pharmacological_substance 607 617	nevirapine
N1008 	Reference T15 MeSH:D019829	nevirapine
T22	Pharmacological_substance 144 165	nonnucleoside analogs
T23	Pharmacological_substance 124 142	nucleoside analogs
T24	Pharmacological_substance 242 262	nonnucleoside analog
T18	Disorder 641 670	methadone withdrawal symptoms
T20	Coreferring_mention 686 698	these agents
T21	Combination 676 685	combining
T34	Combination 199 207	combined
T16	Disorder 0 20	Methadone withdrawal
